CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 1.955
EU - Europa 1.436
AS - Asia 808
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Totale 4.209
Nazione #
US - Stati Uniti d'America 1.901
CN - Cina 419
IE - Irlanda 344
SE - Svezia 263
SG - Singapore 255
FI - Finlandia 238
DE - Germania 203
UA - Ucraina 187
TR - Turchia 124
IT - Italia 76
CA - Canada 54
GB - Regno Unito 45
AT - Austria 38
BE - Belgio 19
NL - Olanda 10
RO - Romania 6
EU - Europa 4
IN - India 4
AU - Australia 2
CL - Cile 2
HK - Hong Kong 2
LT - Lituania 2
LU - Lussemburgo 2
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
SC - Seychelles 1
Totale 4.209
Città #
Chandler 415
Dublin 344
Jacksonville 302
Singapore 203
Dearborn 158
Izmir 119
Ashburn 105
Boardman 93
Nanjing 79
Ann Arbor 78
Beijing 75
San Mateo 72
Princeton 70
Toronto 48
Wilmington 48
Shanghai 46
Vienna 38
Bremen 36
Helsinki 29
Nanchang 26
Parma 26
Hebei 25
Jiaxing 20
Brussels 19
Des Moines 19
Jinan 18
Shenyang 18
Kunming 15
New York 14
Hefei 13
Santa Clara 13
Woodbridge 10
Changsha 9
Seattle 9
Dallas 8
Houston 8
Norwalk 8
Tianjin 8
Trezzano Sul Naviglio 8
Coventry 7
Mestre 6
Munich 6
Grafing 5
Taiyuan 5
Tappahannock 5
Auburn Hills 4
Düsseldorf 4
Falls Church 4
London 4
Ottawa 4
Xian 4
Frankfurt am Main 3
Kocaeli 3
Lanzhou 3
Los Angeles 3
Taizhou 3
Udine 3
Wuhan 3
Zhengzhou 3
Baotou 2
Bologna 2
Borås 2
Chengdu 2
Chicago 2
Fairfield 2
Florence 2
Focsani 2
Fremont 2
Guangzhou 2
Hangzhou 2
Hong Kong 2
Huizen 2
Luxembourg 2
Messina 2
Milan 2
Ningbo 2
Pune 2
Rockville 2
Sydney 2
Timisoara 2
Augusta 1
Bellante 1
Berlin 1
Bolzano 1
Boston 1
Brescia 1
Brno 1
Budapest 1
Castelnuovo Rangone 1
Catania 1
Dalseong-gun 1
Fuzhou 1
Geislingen an der Steige 1
Haikou 1
Harbin 1
Lhasa 1
Madrid 1
Montreal 1
Mountain View 1
Nuremberg 1
Totale 2.796
Nome #
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 129
Antibodies as a source of anti-infective peptides: an update 89
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 85
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 83
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 77
Peptides from the inside of the antibodies are active against infectious agents and tumours 77
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 75
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 74
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 73
Abortive replication of influenza A viruses in HeLa 229 cells 72
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 71
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 70
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 70
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 69
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 69
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 68
Biological characterization of FPV, Ulster 73, replicative cycle. 68
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 67
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 67
Spettro d'azione universale di mimotopi killer antifungini 66
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 66
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 66
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 65
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 65
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 64
Physical characterization of N4-coded messenger RNA 64
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 63
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 62
Control of influenza virus polypeptide synthesis 62
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 62
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 60
Inhibition of late influenza virus genome expression by diamidinophenylindole. 60
Restriction of Influenza virus multiplication induced by PK peptide treatment 59
Effect of coumermycin on influenza A virus replicative cycle. 59
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 59
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 58
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 58
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 57
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 57
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 55
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 55
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 54
Batteriemie da germi anaerobi 54
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 54
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 54
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 53
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 53
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 53
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 53
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 53
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 53
Macromolecular synthesis during abortive infection of KB cells by influenza virus 53
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 52
Different patterns of replication in influenza virus-infected KB cells 52
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 52
Phosphorylation of viral polypeptides in cells infected with influenza virus 52
Different patterns of replication in influenza virus-infected KB cells 52
Viral protein synthesis during replication of bacteriophage T1. 51
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 51
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 50
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 49
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 47
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 47
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 47
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 45
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 40
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 40
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 39
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 37
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 37
Totale 4.222
Categoria #
all - tutte 15.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020567 0 0 0 0 102 98 143 18 46 77 15 68
2020/2021410 5 70 25 1 69 6 33 5 102 7 77 10
2021/2022339 4 3 2 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/2025360 17 83 89 71 100 0 0 0 0 0 0 0
Totale 4.222